There are a couple of things. One might be more active participation and better funding for Canadian participation in international standard-setting bodies. For example, there are understandings that are reached there that, as Troy was mentioning, some countries won't abide by or won't adopt. I'm talking in this case, for example, about products, beta-agonists, used in animal production in Canada, which other countries simply ignore.
The other thing is that when we come up against trade challenges, such as what happened with COOL, the industry put a lot of money, millions and millions of dollars, into that. Certainly funding is an issue as to whether or not we even engage in trying to challenge them up front.